Escape Room at ASH

With a rare disease that was unknown to most doctors and a therapy that hadn’t been promoted before, EUSA Pharma asked us to make a big splash at ASH.

In a sea of booth-sameness, the first priority was to stand out. A booth built to be a giant castle accomplished that. But we needed to do more than get attention, we needed to teach them about iMCD (idiopathic multi-centric Castleman disease) and EUSA’s treatment for it, SYLVANT. Inside the castle was an escape room that took them through the diagnostic process highlighting the most important points along the way.

Watch the case study.

HCPs went through in groups of three or four and had ten minutes to complete the challenge. With a leaderboard prominently displayed there was a lot of heated competition for bragging rights.

Best of all, coming out of the experience they were excited and asking questions about what they got right, what they got wrong—this is where the sales reps stepped in to talk about SYLVANT.

Images from Escape the Castle!

EUSA Pharma

EUSA Pharma came to us to help them launch SYLVANT.

SYLVANT wasn’t completely new, it was developed by another company but never promoted. Now EUSA had recently bought it and needed to get it on HemOnc's’ radar.

Along with a full launch campaign we knew we needed to make an impact at the one place the audience met every year—the American Society of Hematology (ASH) conference.